Old Web
English
Sign In
Acemap
>
authorDetail
>
D. van der Biessen
D. van der Biessen
Erasmus University Rotterdam
Pharmacology
Medicine
Pharmacokinetics
CYP3A4
Taxane
3
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase I safety and pharmacokinetic (PK) study of sunitinib (S) in combination with ifosfamide (I) in patients (pts) with advanced solid tumors (STs)
2016
Journal of Clinical Oncology
Paul Hamberg
N. Steeghs
W. J. Loos
D. van der Biessen
M. den Hollander
Metin Tascilar
J. Verweij
Hans Gelderblom
Stefan Sleijfer
Show All
Source
Cite
Save
Citations (1)
Impact of pazopanib on docetaxel exposure: results of a phase I combination study with two different docetaxel schedules.
2015
Cancer Chemotherapy and Pharmacology
Paul Hamberg
Ron H.J. Mathijssen
P. de Bruijn
C. Leonowens
D. van der Biessen
Ferry A.L.M. Eskens
Stefan Sleijfer
Jaap Verweij
M.J.A. de Jonge
Show All
Source
Cite
Save
Citations (18)
A drug interaction study between ketoconazole and panobinostat (LBH589), an orally active histone deacetylase inhibitor, in patients with advanced cancer
2009
Journal of Clinical Oncology
M DeJonge
Margaret M. Woo
D. van der Biessen
Paul Hamberg
Sunil Sharma
L C Chen
N Myke
Lily Zhao
S. Hirawat
Jaap Verweij
Show All
Source
Cite
Save
Citations (0)
1